共 246 条
[1]
Ardeshna KM(2003)Long-term effect of a watch and wait policy versus immediate systemic treatment for asymptomatic advanced-stage non-Hodgkin lymphoma: a randomised controlled trial Lancet 362 516-522
[2]
Smith P(2007)Sorafenib in advanced clear-cell renal-cell carcinoma N Engl J Med 356 125-134
[3]
Norton A(2009)Sorafenib for treatment of renal cell carcinoma: final efficacy and safety results of the phase III treatment approaches in renal cancer global evaluation trial J Clin Oncol 27 3312-3318
[4]
Hancock BW(2012)Observation as a treatment strategy for advanced renal cell carcinoma-a call for prospective validation Front Oncol 2 155-5799
[5]
Hoskin PJ(2009)Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study J Clin Oncol 27 5794-2281
[6]
MacLennan KA(2007)Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma N Engl J Med 356 2271-2172
[7]
Marcus RE(2003)The genetic basis of cancer of the kidney J Urol 170 2163-418
[8]
Jelliffe A(1997)Spontaneous regression of metastatic renal cancer. Case report and literature review Am J Clin Oncol 20 416-2540
[9]
Vaughan Hudson G(1999)Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma J Clin Oncol 17 2530-124
[10]
Linch DC(2007)Sunitinib versus interferon alfa in metastatic renal-cell carcinoma N Engl J Med 356 115-456